6505-00-400-2054 ( NDC63304-0562-01 , TYLENOL W/CODEINE , NDC00093-0150-01 , NDC00555-030-02 , NDC00045-0513-60 , NDC00406-0484-01 , NDC00093-0150-01 , NDC51285-0303-02 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-00-400-2054 | 6505 | 004002054 | CODEINE PHOSPHATE AND ACETAMINOP | 3335 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 30.000 MILLIGRAMS CODEINE PHOSPHATE ACTIVE INGREDIENT AND 325.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT |
| FEAT | SPECIAL FEATURES | THE ACTIVE INGREDIENT ACETAMINOPHEN CAN BE EITHER 300.000 MG OR 325.000 MG |
| AJCN | PROTECTIVE STORAGE FEATURE | EXPIRATION DATED AND SECURITY STORAGE |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| SUPP | SUPPLEMENTARY FEATURES | USE PREFERRED NSN: 6505-01-527-4077 IN ACCORDANCE WITH THE JDF |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CODEINE PHOSPHATE AND ACETAMINOPHEN TABLETS 100S |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC63304-0562-01 | 1CFS3 | A | 2 | 3 | 4 | ZZ | |
| TYLENOL W/CODEINE | 7M650 | A | 1 | 5 | 4 | ZZ | |
| NDC00093-0150-01 | 0A423 | A | 2 | 5 | 4 | ZZ | |
| NDC00555-030-02 | 56490 | A | 2 | 3 | 4 | ZZ | |
| NDC00045-0513-60 | 7M650 | A | 2 | 3 | 4 | ZZ | |
| NDC00406-0484-01 | 1SJ92 | A | 2 | 3 | 4 | ZZ | |
| NDC00093-0150-01 | 80608 | A | 2 | 3 | 4 | KX | |
| NDC51285-0303-02 | 65974 | A | 2 | 3 | 4 | ZZ |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC63304-0562-01 | 1CFS3 | RANBAXY PHARMACEUTICALS INC. | F | A |
| TYLENOL W/CODEINE | 7M650 | MCNEIL PHARMACEUTICAL CO | F | A |
| NDC00093-0150-01 | 0A423 | CARDINAL HEALTH 100 INC | F | A |
| NDC00555-030-02 | 56490 | BARR LABORATORIES INC. | A | A |
| NDC00045-0513-60 | 7M650 | MCNEIL PHARMACEUTICAL CO | F | A |
| NDC00406-0484-01 | 1SJ92 | MALLINCKRODT INC. | F | A |
| NDC00093-0150-01 | 80608 | LEMMON CO | A | A |
| NDC51285-0303-02 | 65974 | DURAMED PHARMACEUTICALS INC | A | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | X | A | 1 | 03/05/1 | P | 3004909125 | 3335 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| DS | N | I | H | SUITABLE SUBSTITUTE 6505-01-527-4077 | |
| GP | ------- | C | K | U/I CONTAINS 100 TT | |
| DN | 9B----- | N | K | U/I CONTAINS 100 TT | |
| DF | ------- | F | K | U/I CONTAINS 100 TT | |
| DS | N | I | K | U/I CONTAINS 100 TT | |
| DM | Z | 1354--1 | M | K | U/I CONTAINS 100 TT |
| GP | ------- | C | H | SUITABLE SUBSTITUTE 6505-01-527-4077 | |
| DA | C2201X- | A | K | U/I CONTAINS 100 TT | |
| VA | V | K | U/I CONTAINS 100 TT | ||
| DN | 9B----- | N | R | REFER TO NON-STD NON-DMSB REV |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | A | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| DN | SMS | L | 1 | BT | Q | Q | 9B----- | N | |
| DS | SMS | L | 1 | BT | Q | Q | D | ||
| DF | SMS | L | 1 | BT | Q | Q | ------- | F | |
| DM | SMS | L | 1 | BT | Q | Q | Z | 1354--1 | M |
| DA | SMS | L | 1 | BT | Q | Q | C2201X- | A | |
| GP | SMS | L | 1 | BT | Q | Q | ------- | C | |
| VA | I | 0 | BT | Q | Q | V |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|---|---|---|---|
| C | 2 | 2 | 01 | X |
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 058770 | Z | 33400 | W | 532 | Z | 6 | A | M | Y | DRUGS/MEDICINES/VITAMINS NOI |